June 2021
Appendices to: Observations Regarding the Average Sales Price Reimbursement Methodology
Martin J. Edelman, MD, chair of the Department of Hematology/Oncology and associate director for Translational Research at the Fox Chase Cancer Center in Philadelphia, Pennsylvania, discusses the the nuances of rescinded indications in small-cell lung cancer.
Advertisement
Advertisement
Trending on AJMC
1
Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD
2
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
3
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
4
Real-World Data Show MASH Progresses Faster Than Trials Suggest
5